Market Overview:
The liver fibrosis treatment market involves products like anti-fibrotics, anti-scarring agents and other therapeutics which prevent progression of scarring of the liver. Liver fibrosis results from chronic liver damage leading to excessive deposition of extracellular matrix proteins in the liver. It is prevalent in conditions like hepatitis B & C, non-alcoholic fatty liver disease, alcoholic liver disease and hereditary hemochromatosis. Early and accurate ... Read more
Liver fibrosis is a condition where excessive amounts of collagen are deposited in the liver, often caused by conditions like hepatitis or alcohol abuse. Treatments for liver fibrosis aim to slowdown or stop the progression of scarring by addressing the underlying cause of injury to the liver cells. This involves medications, lifestyle changes and in some cases procedures. The global liver fibrosis treatment market consists of drugs for treating fibrosis directly by halting the ... Read more
The liver fibrosis treatment market primarily deals with therapeutic drugs and techniques used to cure liver fibrosis or scarring. Liver fibrosis occurs due to prolonged damage to the liver tissues caused by conditions like non-alcoholic fatty liver disease, alcohol abuse, viral hepatitis, autoimmune hepatitis, etc. This injury triggers the liver cells to deposit excess collagen fibers leading to scarring. Therapies for liver fibrosis include antifibrotic drugs, antiviral medications for ... Read more
